IOVA
Iovance Biotherapeutics, Inc. Common Stock
stockNASDAQ
At CloseNov 6, 2026 3:59:56 PM EST
8.04USD+3.876%(+0.30)12,955,716
Pre-marketNov 6, 2026 9:29:55 AM EST
8.05USD+4.005%(+0.31)
After-hoursNov 6, 2026 4:56:30 PM EST
8.025USD-0.187%(-0.015)
IOVA Financials
In Q3 FY 2026 (ended ), Iovance Biotherapeutics, Inc. Common Stock (IOVA) reported revenue of $121.47M, net income of −$22.27M, operating cash flow of −$4.47M, and assets of $991.21M (filed ).
Loading business breakdowns…